{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:46:19Z","timestamp":1786635979852,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Psychiatry"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0019-5545.70986","type":"journal-article","created":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T01:44:26Z","timestamp":1286588666000},"page":"260","source":"Crossref","is-referenced-by-count":2,"title":["Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms"],"prefix":"10.4103","volume":"52","author":[{"given":"Chittaranjan","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SavitaG","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PraveenP","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5545.70986-1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects","author":"Raskin","year":"2004","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.70986-2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence:A randomised controlled trial","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5545.70986-3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","article-title":"Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: A randomized controlled trial","author":"Johnson","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/0019-5545.70986-4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/archinte.165.14.1600","article-title":"Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers:A randomized controlled trial","author":"Johnson","year":"2005","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0019-5545.70986-5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"For the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group.Topiramate for treating alcohol dependence: A randomized controlled trial","author":"Johnson","year":"2007","journal-title":"JAMA"},{"key":"key-10.4103\/0019-5545.70986-6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/archinte.168.11.1188","article-title":"for the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group.Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial","author":"Johnson","year":"2008","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0019-5545.70986-7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00213-007-0755-6","article-title":"Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers","author":"Reid","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"key-10.4103\/0019-5545.70986-8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.ijo.0803382","article-title":"Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: A randomized, double-blind, placebo-controlled study","author":"Toplak","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"key-10.4103\/0019-5545.70986-9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial","author":"Nickel","year":"2005","journal-title":"Int J Eat Disord"},{"key":"key-10.4103\/0019-5545.70986-10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.jcp.0000162806.46453.38","article-title":"Influence of topiramate on olanzapine-related adiposity in women:A random, double-blind, placebo-controlled study","author":"Nickel","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/0019-5545.70986-11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2005.10.001","article-title":"A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia","author":"Kim","year":"2006","journal-title":"Schizophr Res"},{"key":"key-10.4103\/0019-5545.70986-12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.v68n0204","article-title":"Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: A randomized, double-blind, placebo-controlled study","author":"Tucker","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.70986-13","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4088\/JCP.v67n1105","article-title":"Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: A randomized, placebo-controlled trial","author":"Chengappa","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.70986-14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials","author":"Kushner","year":"2006","journal-title":"Bipolar Disord"},{"key":"key-10.4103\/0019-5545.70986-15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","article-title":"Newer antiepileptic drugs and cognitive issues","author":"Aldenkamp","year":"2003","journal-title":"Epilepsia"},{"key":"key-10.4103\/0019-5545.70986-16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1528-1157.2003.27402.x","article-title":"The effects of adjunctive topiramate on cognitive function in patients with epilepsy","author":"Lee","year":"2003","journal-title":"Epilepsia"},{"key":"key-10.4103\/0019-5545.70986-17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yebeh.2007.02.007","article-title":"The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate","author":"Gomer","year":"2007","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/0019-5545.70986-18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.yebeh.2006.03.006","article-title":"Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up","author":"Lee","year":"2006","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/0019-5545.70986-19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.69.5.636","article-title":"Effects of topiramate on cognitive function","author":"Thompson","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0019-5545.70986-20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/01.wnl.0000238099.36998.6b","article-title":"Effect of topiramate on cognition in obese children","author":"Aarsen","year":"2006","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.70986-21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/01.WNL.0000103285.85821.B3","article-title":"Reversible language regression as an adverse effect of topiramate treatment in children","author":"Gross-Tsur","year":"2004","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.70986-22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1528-1157.2000.tb00322.x","article-title":"A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures","author":"Aldenkamp","year":"2000","journal-title":"Epilepsia"},{"key":"key-10.4103\/0019-5545.70986-23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/01.WNL.0000056637.37509.C6","article-title":"Topiramate and word-finding difficulties in patients with epilepsy","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.70986-24","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4 th ed. Washington, DC: American Psychiatric Association; 1994."},{"key":"key-10.4103\/0019-5545.70986-25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000232737.72555.06","article-title":"Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy","author":"Blum","year":"2006","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.70986-26","first-page":"46","article-title":"Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium","author":"Gualtieri","year":"2006","journal-title":"MedGenMed"},{"key":"key-10.4103\/0019-5545.70986-27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1535-7511.2008.00239.x","article-title":"Cognitive effects of levetiracetam versus topiramate","author":"Meador","year":"2008","journal-title":"Epilepsy Curr"},{"key":"key-10.4103\/0019-5545.70986-28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"key-10.4103\/0019-5545.70986-29","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1526-4610.2005.4501006.x","article-title":"Molecular pharmacology of topiramate: Managing seizures and preventing migraine","author":"White","year":"2005","journal-title":"Headache"},{"key":"key-10.4103\/0019-5545.70986-30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/14656566.7.6.811","article-title":"Topiramate and its clinical applications in epilepsy","author":"Guerrini","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0019-5545.70986-31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tins.2006.07.005","article-title":"Different molecular cascades in different sites of the brain control memory consolidation","author":"Izquierdo","year":"2006","journal-title":"Trends Neurosci"},{"key":"key-10.4103\/0019-5545.70986-32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/ebeh.2001.0285","article-title":"Language disturbances as side effects of topiramate and zonisamide therapy","author":"Ojemann","year":"2001","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/0019-5545.70986-33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14756360701507001","article-title":"Carbonic anhydrase inhibition.Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate","author":"Shank","year":"2008","journal-title":"J Enzyme Inhib Med Chem"},{"key":"key-10.4103\/0019-5545.70986-34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.1987.tb03624.x","article-title":"Zonisamide (CI-912) and cognition: Results from preliminary study","author":"Berent","year":"1987","journal-title":"Epilepsia"},{"key":"key-10.4103\/0019-5545.70986-35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2007.08.002","article-title":"Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients","author":"Park","year":"2008","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/0019-5545.70986-36","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1111\/j.1528-1157.1999.tb00922.x","article-title":"Topiramate","author":"Glauser","year":"1999","journal-title":"Epilepsia"},{"key":"key-10.4103\/0019-5545.70986-37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1034\/j.1399-5618.2001.30406.x","article-title":"Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder","author":"Andrade","year":"2001","journal-title":"Bipolar Disord"},{"key":"key-10.4103\/0019-5545.70986-38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tics.2006.04.003","article-title":"Genes, cognition and dyslexia: Learning to read the genome","author":"Fisher","year":"2006","journal-title":"Trends Cogn Sci"},{"key":"key-10.4103\/0019-5545.70986-39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mrdd.20135","article-title":"Genes, language development, and language disorders","author":"Smith","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"key-10.4103\/0019-5545.70986-40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.seizure.2007.12.003","article-title":"Central nervous system adverse effects of new antiepileptic drugs.A meta-analysis of placebo-controlled studies","author":"Zaccara","year":"2008","journal-title":"Seizure"},{"key":"key-10.4103\/0019-5545.70986-41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.yebeh.2006.05.004","article-title":"Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy","author":"Jansen","year":"2006","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/0019-5545.70986-42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yebeh.2006.11.001","article-title":"Reversible nonfluent aphasia and left frontal hypoperfusion during topiramate treatment","author":"Cappa","year":"2007","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/0019-5545.70986-43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1034\/j.1399-5618.2001.30501.x","article-title":"The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder","author":"Chengappa","year":"2001","journal-title":"Bipolar Disord"},{"key":"key-10.4103\/0019-5545.70986-44","first-page":"77","article-title":"Neurology of language","author":"Tranel","year":"1992","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"key-10.4103\/0019-5545.70986-45","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1073\/pnas.0805234105","article-title":"Ventral and dorsal pathways for language","author":"Saur","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0019-5545.70986-46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1526-4610.2006.00348_1.x","article-title":"Donepezil treatment of topiramate-related cognitive dysfunction","author":"Wheeler","year":"2006","journal-title":"Headache"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:52:27Z","timestamp":1786632747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-5545.70986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["70986"],"URL":"https:\/\/doi.org\/10.4103\/0019-5545.70986","relation":{},"ISSN":["0019-5545"],"issn-type":[{"value":"0019-5545","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}